Table 8.
Mortality and follow up of all patients, depending on FFP-classification and on type of treatment (P-group versus O-group)
| FFP-type | FFP Type I-IV | FFP Type I | FFP Type II | FFP Type III | FFP Type IV | p-value |
|---|---|---|---|---|---|---|
| Number of operated patients | 140 | 2 | 52 | 18 | 68 | |
| One-year mortality (%) | 9.7 | 0 | 8 | 12.5 | 11.8 | |
| Two-year mortality (%) | 15.7 | 0 | 8 | 26 | 19.5 | |
| Five-year mortality (%) | 41.5 | 0 | 33.2 | 26 | 51 | |
| Overall mortality | 0.428 | |||||
| Patients who died before follow up (%) | 34 (24.3) | 0 | 11 (21.2) | 5 (27.8) | 18 (26.5) | |
| Patients lost to follow up (%) | 15 (10.7) | 0 | 6 (11.5) | 2 (11.1) | 7 (10.3) | |
| Patients with follow-up (%) | 91 (65.0) | 2 | 35 (67.3) | 11 (61.1) | 43 (63.2) | |
| Surviving patients with follow up (%) | 91 (85.8) | 2 | 35 (85.4) | 11 (84.6) | 43 (86.0) | |
| Median follow up time (months) | 40 | 42 | 42 | 47 | 39 | |
| Patients with SF-8 (n, %) | 60/91 (65.9) | 2/2 | 16/35 (45.7) | 5/11 (45.5) | 37/43 (86.0) | |
| Median SF-8 physical (PCS) | 32.43 | 46.12 | 29.39 | 27.88 | 32.88 | 0.61 |
| Min SF-8 physical | 17.34 | 34.92 | 17.34 | 22.54 | 18.59 | |
| Max SF-8 physical | 57.32 | 57.32 | 56.68 | 42.43 | 55.50 | |
| Median SF-8 mental (MCS) | 54.42 | 56.50 | 55.42 | 50.21 | 54.67 | 0.32 |
| Min SF-8 mental | 17.71 | 53.93 | 19.83 | 17.85 | 17.71 | |
| Max SF-8 mental | 69.22 | 59.08 | 65.17 | 58.61 | 69.22 | |
| Patients with PMS (n, %) | 91/91 (100.0) | 2/2 | 35/35 (100.0) | 11/11 (100.0) | 43/43 (100.0) | |
| Median PMS | 5 | 6.5 | 6 | 3 | 5 | 0.20 |
| Min PMS | 0 | 4 | 0 | 0 | 0 | |
| Max PMS | 9 | 9 | 9 | 9 | 9 | |
| Patients with NRS (n, %) | 89/91 (97.8) | 2/2 | 35/35 (100.0) | 10/11 (90.9) | 42/43 (97.7) | |
| Median NRS | 4 | 0 | 5 | 4 | 4 | 0.86 |
| Min NRS | 0 | 0 | 0 | 0 | 0 | |
| Max NRS | 10 | 0 | 9 | 7 | 10 | |
| Type of treatment | All patients | P-group | O-group | p value | ||
| Number of operated patients | 140 | 99 | 41 | |||
| One-year mortality (%) | 9.7 | 11.5 | 7.7 | |||
| Two-year mortality (%) | 15.7 | 12.8 | 23.7 | |||
| Five-year mortality (%) | 41.5 | 43.3 | 32.4 | |||
| Overall mortality | 0.831 | |||||
| Patients who died before follow up (%) | 34 (24.3) | 26 (26.3) | 8 (19.5) | |||
| Patients lost to follow up (%) | 15 (10.7) | 13 (13.1) | 2 (4.9) | |||
| Patients with follow-up (%) | 91 (65.0) | 60 (60.6) | 31 (75.6) | |||
| Surviving patients with follow up (%) | 91 (85.8) | 60 (82.2) | 31 (93.9) | |||
| Median follow up time (months) | 40 | 39.6 | 40.5 | |||
| Patients with SF-8 (n, %) | 60/91 (65.9) | 38/60 (63.3) | 22/31 (71.0) | |||
| Median SF-8 physical (PCS) | 32.43 | 32.64 | 31.22 | 0.68 | ||
| Min SF-8 physical | 17.34 | 17.34 | 18.59 | |||
| Max SF-8 physical | 57.32 | 56.68 | 57.32 | |||
| Median SF-8 mental (MCS) | 54.42 | 54.26 | 58.82 | 0.22 | ||
| Min SF-8 mental | 17.71 | 17.71 | 17.85 | |||
| Max SF-8 mental | 69.22 | 67.27 | 69.22 | |||
| Patients with PMS (n, %) | 91/91 (100.0) | 60/60 (100.0) | 31/31 (100.0) | |||
| Median PMS | 5 | 6 | 4 | 0.07 | ||
| Min PMS | 0 | 0 | 0 | |||
| Max PMS | 9 | 9 | 9 | |||
| Patients with NRS (n, %) | 89/91 (97.8) | 59/60 (98.3) | 30/31 (96.8) | |||
| Median NRS | 4 | 3 | 4 | 0.30 | ||
| Min NRS | 0 | 0 | 0 | |||
| Max NRS | 10 | 9 | 10 |
P-values below 0.05 are shown in bold